The Effect of Obesity on Response to Neoadjuvant Therapy in Locally Advanced Gastric Cancer.
Ayşegül SakinSuleyman SahinAbdullah SakinMehmet Naci AldemirIrfan BayramMehmet Cetin KotanPublished in: Asian Pacific journal of cancer prevention : APJCP (2020)
In our study, we found that pre-treatment obesity did not affect the TRG in clinical stage III GC patients. However, a better TRG status was associated with improved survival.<br />.
Keyphrases
- locally advanced
- rectal cancer
- insulin resistance
- metabolic syndrome
- end stage renal disease
- weight loss
- type diabetes
- ejection fraction
- newly diagnosed
- squamous cell carcinoma
- neoadjuvant chemotherapy
- high fat diet induced
- chronic kidney disease
- weight gain
- prognostic factors
- radiation therapy
- stem cells
- adipose tissue
- phase ii study
- mesenchymal stem cells
- combination therapy
- physical activity
- free survival